Peter Liljeström

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF VIROLOGY. 2019;93(7):e00055-e00019
Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV
Marin MQ; Perez P; Ljungberg K; Sorzano COS; Gomez CE; Liljestrom P; Esteban M; Garcia-Arriaza J
Article: ONCOIMMUNOLOGY. 2018;7(10):e1487913
Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens
van de Wall S; Ljungberg K; Ip PP; Boerma A; Knudsen ML; Nijman HW; Liljestrom P; Daemen T
Article: SCIENTIFIC REPORTS. 2018;8(1):12459
DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost
Ohlund P; Garcia-Arriaza J; Zusinaite E; Szurgot I; Mannik A; Kraus A; Ustav M; Merits A; Esteban M; Liljestrom P; Ljungberg K
Article: JOURNAL OF VIROLOGY. 2018;92(11):e00363-e00318
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins
Lazaro-Frias A; Gomez-Medina S; Sanchez-Sampedro L; Ljungberg K; Ustav M; Liljestrom P; Munoz-Fontela C; Esteban M; Garcia-Arriaza J
Article: NATURE COMMUNICATIONS. 2017;8(1):1404
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
Zhu J; De Tenbossche CGP; Cane S; Colau D; Van Baren N; Lurquin C; Schmitt-Verhulst A-M; Liljestrom P; Uyttenhove C; Van den Eynde BJ
Article: JCI INSIGHT. 2017;2(6):e83527
Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus
Roques P; Ljungberg K; Kuemmerer BM; Gosse L; Dereuddre-Bosquet N; Tchitchek N; Hallengard D; Garcia-Arriaza J; Meinke A; Esteban M; Merits A; Le Grand R; Liljestrom P
Article: GENE THERAPY. 2016;23(10):753-759
T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates
Rollier CS; Verschoor EJ; Verstrepen BE; Drexhage JAR; Paranhos-Baccala G; Liljestrom P; Sutter G; Arribillaga L; Lasarte JJ; Bartosch B; Cosset F-L; Inchauspe G; Heeney JL
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2016;113(3):E368-E377
H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice
Tesoriero C; Codita A; Zhang M-D; Cherninsky A; Karlsson H; Grassi-Zucconi G; Bertini G; Harkany T; Ljungberg K; Liljestrom P; Hokfelt TGM; Bentivoglio M; Kristensson K
Article: IMMUNITY, INFLAMMATION AND DISEASE. 2015;3(2):82-93
Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques.
Borthwick NJ; Rosario M; Schiffner T; Bowles E; Ahmed T; Liljeström P; Stewart-Jones GE; Drijfhout JW; Melief CJM; Hanke T
Article: VECTOR-BORNE AND ZOONOTIC DISEASES. 2015;15(4):250-257
Therapeutics and Vaccines Against Chikungunya Virus
Ahola T; Courderc T; Ng LFP; Hallengard D; Powers A; Lecuit M; Esteban M; Merits A; Roques P; Liljestrom P
Article: JOURNAL OF GENERAL VIROLOGY. 2015;96(Pt 3):565-570
Modification of a salmonid alphavirus replicon vector for enhanced expression of heterologous antigens
Guo T-C; Johansson DX; Liljestrom P; Evensen O; Haugland O
Article: PLOS ONE. 2015;10(2):e0117042
Alphavirus Replicon DNA Expressing HIV Antigens Is an Excellent Prime for Boosting with Recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 Protein Antigen
Knudsen ML; Ljungberg K; Tatoud R; Weber J; Esteban M; Liljestrom P
Article: JOURNAL OF VIROLOGY. 2014;88(22):13333-13343
Prime-Boost Immunization Strategies against Chikungunya Virus
Hallengard D; Lum F-M; Kuemmerer BM; Lulla A; Lulla V; Garcia-Arriaza J; Fazakerley JK; Roques P; Le Grand R; Merits A; Ng LFP; Esteban M; Liljestrom P
Article: JOURNAL OF VIROLOGY. 2014;88(21):12438-12451
Kinetic and Phenotypic Analysis of CD8⁺ T Cell Responses after Priming with Alphavirus Replicons and Homologous or Heterologous Booster Immunizations
Knudsen ML; Ljungberg K; Kakoulidou M; Kostic L; Hallengard D; Garcia-Arriaza J; Merits A; Esteban M; Liljestrom P
Article: JOURNAL OF VIROLOGY. 2014;88(6):3527-3547
A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection
Garcia-Arriaza J; Cepeda V; Hallengaerd D; Sorzano COS; Kuemmerer BM; Liljestroem P; Esteban M
Article: JOURNAL OF VIROLOGY. 2014;88(5):2858-2866
Novel Attenuated Chikungunya Vaccine Candidates Elicit Protective Immunity in C57BL/6 mice
Hallengard D; Kakoulidou M; Lulla A; Kuemmerer BM; Johansson DX; Mutso M; Lulla V; Fazakerley JK; Roques P; Le Grand R; Merits A; Liljestrom P
Article: METHODS IN MOLECULAR BIOLOGY. 2014;1121:147-154
Intradermal electroporation of RNA.
Knudsen ML; Ljungberg K; Liljeström P; Johansson DX
Article: PLOS ONE. 2014;9(7):e100184
A 6K-Deletion Variant of Salmonid Alphavirus Is Non-Viable but Can Be Rescued through RNA Recombination
Guo T-C; Johansson DX; Haugland O; Liljestrom P; Evensen O
Article: VIROLOGY JOURNAL. 2013;10:235
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout
Glaesker S; Lulla A; Lulla V; Couderc T; Drexler JF; Liljestrom P; Lecuit M; Drosten C; Merits A; Kuemmerer BM
Article: PLOS ONE. 2013;8(6):e65964
The Adjuvant Activity of Alphavirus Replicons Is Enhanced by Incorporating the Microbial Molecule Flagellin into the Replicon
Knudsen ML; Johansson DX; Kostic L; Nordstron EKL; Tegerstedt K; Pasetto A; Applequist SE; Ljungberg K; Sirard J-C; Liljestrom P
Article: JOURNAL OF VIROLOGY. 2012;86(13):7384-7392
Differential Impact of Interferon Regulatory Factor 7 in Initiation of the Type I Interferon Response in the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System versus the Periphery
Christensen JE; Fenger C; Issazadeh-Navikas S; Krug A; Liljestrom P; Goriely S; Paludan SR; Finsen B; Christensen JP; Thomsen AR
Article: JOURNAL OF VIROLOGY. 2012;86(8):4082-4090
Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine
Knudsen ML; Mbewe-Mvula A; Rosario M; Johansson DX; Kakoulidou M; Bridgeman A; Reyes-Sandoval A; Nicosia A; Ljungberg K; Hanke T; Liljestrom P
Article: PLOS ONE. 2012;7(1):e29732
Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
Johansson DX; Ljungberg K; Kakoulidou M; Liljestrom P
Article: PLOS ONE. 2012;7(7):e40743
Host Gene Expression Signatures Discriminate between Ferrets Infected with Genetically Similar H1N1 Strains
Ljungberg K; McBrayer A; Camp JV; Chu Y-K; Tapp R; Noah DL; Grimes S; Proctor ML; Liljestrom P; Jonsson CB; Bruder CE
Article: PLOS ONE. 2012;7(5):e37104
De-Novo Transcriptome Sequencing of a Normalized cDNA Pool from Influenza Infected Ferrets
Camp JV; Svensson TL; McBrayer A; Jonsson CB; Liljestrom P; Bruder CE
Article: VACCINE. 2011;29(46):8309-8316
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pot and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)
Garcia F; Lopez Bernaldo de Quiros JC; Gomez CE; Perdiguero B; Najera JL; Jimenez V; Garcia-Arriaza J; Guardo AC; Perez I; Diaz-Brito V; Sanchez Conde M; Gonzalez N; Alvarez A; Alcami J; Luis Jimenez J; Pich J; Albert Arnaiz J; Maleno MJ; Leon A; Angeles Munoz-Fernandez M; Liljestrom P; Weber J; Pantaleo G; Gatell JM; Plana M; Esteban M
Article: PLOS PATHOGENS. 2011;7(5):e1002041
Protective Efficacy of Serially Up-Ranked Subdominant CD8⁺ T Cell Epitopes against Virus Challenges
Im E-J; Hong JP; Roshorm Y; Bridgeman A; Letourneau S; Liljestrom P; Potash MJ; Volsky DJ; McMichael AJ; Hanke T
Article: VIROLOGY JOURNAL. 2011;8:36
Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
Naslund TI; Kostic L; Nordstrom EKL; Chen M; Liljestrom P
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2010;40(7):1973-1984
Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques
Rosario M; Bridgeman A; Quakkelaar ED; Quigley MF; Hill BJ; Knudsen ML; Ammendola V; Ljungberg K; Borthwick N; Im E-J; McMichael AJ; Drijfhout JW; Greenaway HY; Venturi V; Douek DC; Colloca S; Liljestrom P; Nicosia A; Price DA; Melief CJM; Hanke T
Article: VIRAL IMMUNOLOGY. 2009;22(5):309-319
Preclinical Evaluation of the Immunogenicity of C-Type HIV-1-Based DNA and NYVAC Vaccines in the Balb/C Mouse Model
Wild J; Bieler K; Koestler J; Frachette M-J; Jeffs S; Vieira S; Esteban M; Liljestroem P; Pantaleo G; Wolf H; Wagner R
Article: JOURNAL OF VIROLOGY. 2009;83(11):5881-5889
Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens
Mooij P; Balla-Jhagjhoorsingh SS; Beenhakker N; van Haaften P; Baak I; Nieuwenhuis IG; Heidari S; Wolf H; Frachette M-J; Bieler K; Sheppard N; Harari A; Bart P-A; Liljestrom P; Wagner R; Pantaleo G; Heeney JL
Article: VACCINE. 2008;26(25):3153-3161
EV01:: A phase I trial in healthy HIV negative volunteers to evaluate a clade CHIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
Bart P-A; Goodall R; Barber T; Harari A; Guimaraes-Walker A; Khonkarly M; Sheppard NC; Bangala Y; Frachette M-J; Wagner R; Liljestrom P; Kraehenbuhl J-P; Girard M; Goudsmit J; Esteban M; Heeney J; Sattentau Q; McCormack S; Babiker A; Pantaleo G; Weber J
Article: JOURNAL OF EXPERIMENTAL MEDICINE (JEM). 2008;205(1):63-77
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Harari A; Bart P-A; Stoehr W; Tapia G; Garcia M; Medjitna-Rais E; Burnet S; Cellerai C; Erlwein O; Barber T; Moog C; Liljestrom P; Wagner R; Wolf H; Kraehenbuhl J-P; Esteban M; Heeney J; Frachette M-J; Tartaglia J; McCormack S; Babiker A; Weber J; Pantaleo G
Article: JOURNAL OF VIROLOGY. 2007;81(16):8677-8684
Semliki forest virus nonstructural protein 2 is involved in suppression of the type I interferon response
Breakwell L; Dosenovic P; Hedestam GBK; D'Amato M; Liljestrom P; Fazakerley J; McInerney GM
Article: JOURNAL OF IMMUNOLOGY. 2007;178(11):6761-6769
Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor
Naslund TI; Uyttenhove C; Nordstrom EKL; Colau D; Warnier G; Jondal M; Van den Eynde BJ; Liljestrom P
Article: VACCINE. 2007;25(15):2863-2885
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1_BX08 gp120 and HIV-1_IIIB Gag-Pol-Nef proteins of clade B
Gomez CE; Najera JL; Jimenez EP; Jimenez V; Wagner R; Graf M; Frachette M-J; Liljestrom P; Pantaleo G; Esteban M
Article: VACCINE. 2007;25(11):1969-1992
Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C
Elena Gomez C; Luis Najera J; Jimenez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette M-J; Pantaleo G; Wolf H; Liljestrom P; Wagner R; Esteban M
Article: SCIENCE. 2006;314(5801):997-1001
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates
Pichlmair A; Schulz O; Tan CP; Naslund TI; Liljestrom P; Weber F; Sousa CRE
Article: JOURNAL OF VIROLOGY. 2006;80(14):7100-7110
Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling
Hidmark AS; Nordstrom EKL; Dosenovic P; Forsell MNE; Liljestrom P; Hedestam GBK
Article: GUT. 2006;55(2):266-274
Relation between viral fitness and immune escape within the hepatitis C virus protease
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Article: VIROLOGY. 2005;341(2):190-202
Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles
Sundbäck M; Douagi I; Dayaraj C; Forsell MNE; Nordström EKL; McInerney GM; Spångberg K; Tjäder L; Bonin E; Sundström M; Liljeström P; Hedestam GBK
Article: JOURNAL OF VIROLOGY. 2005;79(17):10902-10914
Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by Semliki Forest virus
Forsell MNE; Li YX; Sundbäck M; Svehla K; Liljeström P; Mascola JR; Wyatt R; Hedestam GBK
Article: JOURNAL OF VIROLOGY. 2005;79(16):10376-10385
Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88
Hidmark Å; McInerney GM; Nordström EKL; Douagi I; Werner KM; Liljeström P; Hedestam GBK
Article: MOLECULAR BIOLOGY OF THE CELL. 2005;16(8):3753-3763
Importance of eIF2α phosphorylation assembly in alphavirus translation and stress granule regulation
McInerney GM; Kedersha NL; Kaufman RJ; Anderson P; Liljeström P
Article: JOURNAL OF VIROLOGY. 2005;79(12):7942-7948
Reversible acid-induced inactivation of the membrane fusion protein of Semliki Forest virus
Waarts BL; Smit JM; Aneke OJC; McInerney GM; Liljeström P; Bittman R; Wilschut J
Article: JOURNAL OF VIROLOGY. 2005;79(5):2964-2972
MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells
Chen M; Barnfield C; Näslund TI; Fleeton MN; Liljeström P
Article: NATURE. 2005;433(7028):887-892
Toll-like receptor 3 promotes cross-priming to virus-infected cells
Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Sousa CRE
Article: JOURNAL OF GENERAL VIROLOGY. 2005;86(Pt 2):349-354
Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1
Nordström EKL; Forsell MNE; Barnfield C; Bonin E; Hanke T; Sundström M; Karlsson GB; Liljeström P
Article: JOURNAL OF GENERAL VIROLOGY. 2004;85(Pt 10):2915-2924
Vaccine protection from CD4⁺ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens
Koopman G; Mortier D; Hofman S; Niphuis H; Fagrouch Z; Norley S; Sutter G; Liljeström P; Heeney JL
Article: VACCINE. 2004;22(25-26):3386-3394
DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model
Penttilä T; Tammiruusu A; Liljeström P; Sarvas M; Mäkelä PH; Vuola JM; Puolakkainen M
Article: VIROLOGY. 2004;325(2):200-206
Semliki Forest virus produced in the absence of the 6K protein has an altered spike structure as revealed by decreased membrane fusion capacity
McInerney GM; Smit JM; Liljeström P; Wilschut J
Article: VACCINE. 2004;22(21-22):2701-2712
Immunization with PfEMP1-DBL1α generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes
Chen QJ; Pettersson F; Vogt AM; Schmidt B; Ahuja S; Liljeström P; Wahlgren M
Article: GENE THERAPY. 2004;11(6):522-533
Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene
Frelin L; Ahlén G; Alheim M; Weiland O; Barnfield C; Liljeström P; Sällberg M
Article: METHODS IN MOLECULAR BIOLOGY. 2004;246:543-557
Delivery and expression of heterologous genes in mammalian cells using self-replicating alphavirus vectors.
Karlsson GB; Liljeström P
Article: GENE THERAPY. 2003;10(8):686-699
Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo
Frelin L; Alheim M; Chen A; Söderholm J; Rozell B; Barnfield C; Liljeström P; Sällberg M
Article: JOURNAL OF GENERAL VIROLOGY. 2003;84(Pt 2):361-368
Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine
Hanke T; Barnfield C; Wee EGT; Ågren L; Samuel RV; Larke N; Liljeström P
Article: METHODS IN MOLECULAR MEDICINE. 2003;87:69-82
Live viral vectors: Semliki Forest virus.
Karlsson GB; Liljeström P
Article: VACCINE. 2002;20(23-24):2921-2927
Comparison of the efficacy of early versus late viral proteins in vaccination against SIV
Stittelaar KJ; Gruters RA; Schutten M; van Baalen CA; van Amerongen G; Cranage M; Liljeström P; Sutter G; Osterhaus ADME
Article: JOURNAL OF IMMUNOLOGY. 2002;168(9):4391-4398
Competition between CTL narrows the immune response induced by prime-boost vaccination protocols
Palmowski MJ; Choi EML; Hermans IF; Gilbert SC; Chen JL; Gileadi U; Salio M; Van Pel A; Man S; Bonin E; Liljestrom P; Dunbar PR; Cerundolo V
Article: INTERNATIONAL JOURNAL OF CANCER. 2002;98(4):554-560
Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression
Colmenero P; Chen M; Castañoz-Velez E; Liljeström P; Jondal M
Article: JOURNAL OF GENERAL VIROLOGY. 2002;83(Pt 2):369-381
Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles
Brinster C; Chen M; Boucreux D; Paranhos-Baccala G; Liljeström P; Lemmonier F; Inchauspé G
Article: GENE THERAPY. 2001;8(17):1307-1314
Recombinant Semliki Forest virus vaccine vectors:: the route of injection determines the localization of vector RNA and subsequent T cell response
Colmenero P; Berglund P; Kambayashi T; Biberfeld P; Liljeström P; Jondal M
Article: VACCINE. 2001;19(28-29):3877-3884
A recombinant Semliki Forest virus particle vaccine encoding the prME and NSl proteins of louping ill virus is effective in a sheep challenge model
Morris-Downes MM; Sheahan BJ; Fleeton MN; Liljeström P; Reid HW; Atkins GJ
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2001;54(1-2):117-124
Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332
Andersson C; Vasconcelos NM; Sievertzon M; Haddad D; Liljeqvist S; Berglund P; Liljeström P; Ahlborg N; Ståhl S; Berzins K
Article: JOURNAL OF VIROLOGY. 2001;75(10):4625-4632
M-X-I motif of semliki forest virus capsid protein affects nucleocapsid assembly
Skoging-Nyberg U; Liljeström P
Article: VACCINE. 2001;19(25-26):3526-3536
Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara
Nilsson C; Mäkitalo B; Berglund P; Bex F; Liljeström P; Sutter G; Erfle V; ten Haaft P; Heeney J; Biberfeld G; Thorstensson R
Article: CURRENT PROTOCOLS IN MOLECULAR BIOLOGY. 2001;Chapter 16:Unit16.20-16.20.16
Expression of proteins using Semliki Forest virus vectors.
Liljeström P; Garoff H
Article: JOURNAL OF INFECTIOUS DISEASES. 2001;183(9):1395-1398
Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus
Fleeton MN; Chen M; Berglund P; Rhodes G; Parker SE; Murphy M; Atkins GJ; Liljeström P
Article: VACCINE. 2001;19(15-16):1978-1988
Semliki Forest virus-based vaccines:: persistence, distribution and pathological analysis in two animal systems
Morris-Downes MM; Phenix KV; Smyth J; Sheahan BJ; Lileqvist S; Mooney DA; Liljeström P; Todd D; Atkins GJ
Article: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 2000;29(4):247-253
Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen
Andersson C; Liljeström P; Ståhl S; Power UF
Article: VIROLOGY. 2000;276(2):259-270
Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki Forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens
Vidalin O; Fournillier A; Renard N; Chen M; Depla E; Boucreux D; Brinster C; Baumert T; Nakano I; Fukuda Y; Liljeström P; Trépo C; Inchauspé G
Article: JOURNAL OF MEDICAL PRIMATOLOGY. 2000;29(3-4):268-273
A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens
Heeney JL; Koopman G; Rosenwirth B; Bogers W; van Dijk J; Nieuwenhuis I; Niphuis H; ten Haaft P; Hanke T; Rhodes G; Berglund P; Burny A; Bex F; Sutter G; Liljeström P
Article: ARCHIVES OF VIROLOGY. 2000;145(6):1225-1230
A conserved leucine in the cytoplasmic domain of the Semliki Forest virus spike protein is important for budding
Skoging-Nyberg U; Liljeström P
Article: JOURNAL OF GENERAL VIROLOGY. 2000;81(Pt 3):749-758
Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine
Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
Article: MARINE BIOTECHNOLOGY. 2000;2(1):27-37
Cell culture evaluation of the Semliki Forest virus expression system as a novel approach for antigen delivery and expression in fish
Phenix KV; McKenna B; Fitzpatrick R; Vaughan L; Atkins G; Liljestrom P; Todd D
Article: GENE THERAPY. 1999;6(10):1728-1733
Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene
Colmenero P; Liljeström P; Jondal M
Article: JOURNAL OF GENERAL VIROLOGY. 1999;80:1189-1198
Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge
Fleeton MN; Sheahan BJ; Gould EA; Atkins GJ; Liljeström P
Article: CURRENT OPINION IN MOLECULAR THERAPEUTICS. 1999;1(2):244-251
Non-viral amplification systems for gene transfer:: Vectors based on alphaviruses
Smerdou C; Liljeström P
Article: VACCINE. 1999;17(5):497-507
Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice
Berglund P; Fleeton MN; Smerdou C; Liljeström P
Article: JOURNAL OF VIROLOGY. 1999;73(2):1092-1098
Two-helper RNA system for production of recombinant Semliki Forest virus particles
Smerdou C; Liljeström P
Article: JOURNAL OF MOLECULAR BIOLOGY. 1998;279(4):865-872
Role of the C-terminal tryptophan residue for the structure-function of the alphavirus capsid protein
Skoging U; Liljeström P
Article: NATURE BIOTECHNOLOGY. 1998;16(6):562-565
Enhancing immune responses using suicidal DNA vaccines
Berglund P; Smerdou C; Fleeton MN; Tubulekas I; Liljeström P
Article: JOURNAL OF VIROLOGY. 1998;72(4):2825-2831
Suppressors of cleavage-site mutations in the p62 envelope protein of Semliki Forest virus reveal dynamics in spike structure and function
Tubulekas I; Liljeström P
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1997;13(17):1487-1495
Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus
Berglund P; QuesadaRolander M; Putkonen P; Biberfeld G; Thorstensson R; Liljestrom P
Article: BIOESSAYS. 1997;19(11):993-1000
Budding of enveloped viruses from the plasma membrane
Cadd TL; Skoging U; Liljestrom P
Article: GENE THERAPY. 1997;4(4):367-374
Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: Expression of IL-12 in human tumor cells
Zhang J; AsselinPaturel C; Bex F; Bernard J; Chehimi J; Willems F; Caignard A; Berglund P; Liljestrom P; Burny A; Chouaib S
Article: STRUCTURE. 1996;4(5):519-529
Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid
Skoging U; Vihinen M; Nilsson L; Liljestrom P
Article: TRENDS IN BIOTECHNOLOGY. 1996;14(4):130-134
Alphaviruses as vectors for gene delivery
Berglund P; Tubulekas I; Liljestrom P
Article: JOURNAL OF VIROLOGY. 1996;70(3):1953-1960
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant semliki forest virus gp160 vaccine and by a gp120 subunit vaccine
Mossman SP; Bex F; Berglund P; Arthos J; ONeil SP; Riley D; Maul DH; Bruck C; Momin P; Burny A; Fultz PN; Mullins JI; Liljestrom P; Hoover EA
Article: MOLECULAR BIOTECHNOLOGY. 1996;5(1):33-38
Manipulation of the Semliki Forest virus genome and its potential for vaccine construction
Atkins GJ; Sheahan BJ; Liljestrom P
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1995;92(7):3009-3013
GENERATION OF CYTOTOXIC AND HUMORAL IMMUNE-RESPONSES BY NONREPLICATIVE RECOMBINANT SEMLIKI-FOREST-VIRUS
ZHOU XZ; BERGLUND P; ZHAO HX; LILJESTROM P; JONDAL M
Article: JOURNAL OF VIROLOGY. 1995;69(1):469-475
THE 6-KILODALTON MEMBRANE-PROTEIN OF SEMLIKI FOREST VIRUS IS INVOLVED IN THE BUDDING PROCESS
LOEWY A; SMYTH J; VONBONSDORFF CH; LILJESTROM P; SCHLESINGER MJ
Visa fler

Alla övriga publikationer

Review: JOURNAL OF INTERNAL MEDICINE. 2015;278(4):335-353
A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden
Feltelius N; Persson I; Ahlqvist-Rastad J; Andersson M; Arnheim-Dahlstrom L; Bergman P; Granath F; Adori C; Hokfelt T; Kuhlmann-Berenzon S; Liljestrom P; Maeurer M; Olsson T; Ortqvist A; Partinen M; Salmonson T; Zethelius B
Review: EXPERT REVIEW OF VACCINES. 2015;14(2):177-194
Self-replicating alphavirus RNA vaccines
Ljungberg K; Liljestrom P
Review: VACCINE. 2007;25(14):2567-2574
Viral vectors for malaria vaccine development
Li S; Locke E; Bruder J; Clarke D; Doolan DL; Havenga MJE; Hill AVS; Liljestrom P; Monath TP; Naim HY; Ockenhouse C; Tang D-CC; Van Kampen KR; Viret J-F; Zavala F; Dubovsky F
Published conference paper: JOURNAL OF INFECTIOUS DISEASES. 2005;192(5):920-929
Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting
Rollier C; Verschoor EJ; Paranhos-Baccala G; Drexhage JAR; Verstrepen BE; Berland JL; Himoudi N; Barnfield C; Liljestrom P; Lasarte JJ; Ruiz J; Inchauspe G; Heeney JL
Published conference paper: JOURNAL OF MEDICAL PRIMATOLOGY. 2004;33(5-6):251-261
T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge
Michelini Z; Negri DRM; Baroncelli S; Catone S; Comini A; Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Mancini MG; Farcomeni S; Fagrouch Z; Ciccozzi M; Rovetto C; Liljestrom P; Norley S; Heeney J; Titti F
Review: JOURNAL OF GENERAL VIROLOGY. 1999;80:2287-2297
The molecular pathogenesis of Semliki Forest virus:: a model virus made useful?
Atkins GJ; Sheahan BJ; Liljeström P
Published conference paper: JOURNAL OF MEDICAL PRIMATOLOGY. 1999;28(4-5):195-205
An anti-HIV strategy combining chemotherapy and therapeutic vaccination
Rosenwirth B; Bogers WMJM; Nieuwenhuis IG; Ten Haaft P; Niphuis H; Kuhn EM; Bischofberger N; Erfle V; Sutter G; Berglund P; Liljestrom P; Uberla K; Heeney JL
Published conference paper: GENE. 1997;190(1):191-195
Alphavirus expression vectors and their use as recombinant vaccines: A minireview
Tubulekas I; Berglund P; Fleeton M; Liljestrom P
Editorial comment: GENE. 1997;190(1):1
Eukaryotic expression vector systems: Biology and applications - Preface
Hasnain SE; Roy P; Liljestrom P
Published conference paper: JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH. 1995;15(1-4):23-32
HIGH-LEVEL EXPRESSION OF G-PROTEIN-COUPLED RECEPTORS WITH THE AID OF THE SEMLIKI-FOREST-VIRUS EXPRESSION SYSTEM
LUNDSTROM K; MILLS A; ALLET E; CESZKOWSKI K; AGUDO G; CHOLLET A; LILJESTROM P

Anställningar

Professor Emeritus/Emerita, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2024-2026

Examina och utbildning

Docent, Helsingfors universitet, Helsingfors universitet, 1987

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI